Specific C Cid LF Dig Supp is a chewable formulation specially developed for small dogs (approximately 2 kg), which combines anti-parasitic support and digestive wellbeing in a single product. The package contains 3 palatable tablets, easy to administer directly or mixed with food thanks to an organoleptic profile optimized for spontaneous acceptance. This practical solution offers effective control of external parasites and functional ingredients that support the balance of the digestive system.
The following technical sheet provides details on use, composition and safety, guiding the owner and veterinarian in correct use to maximize therapeutic benefits.
Therapeutic Indications
The product is indicated for the integrated treatment of ectoparasite infestations (fleas, ticks) and for gastrointestinal support in dogs weighing approximately 2 kg. The combined action reduces the parasitic load, preventing relapses, and supports digestive function by stabilizing the intestinal microflora. It is particularly useful for sensitive individuals, with a history of digestive disorders or in convalescence. Clinically, it can be included in the management of flea allergy dermatitis (FAD) and in the treatment of related skin irritations, adapting administration to seasonality and epidemiological risk.
Composition
Each chewable tablet balances efficacy and tolerability. The formula includes components for parasite control ("cid"), microbiota health agents ("dig") and extended release technologies ("lf") to reduce the frequency of administration. The wording "supp" indicates the nature of functional support. The excipients, including starch bases and natural flavours, guarantee stability and high palatability, minimizing the systemic impact in favor of a targeted action on the skin and digestive system.
Contraindications
Do not use in case of known hypersensitivity to the components. Use in underweight puppies (below the 2 kg range) must only occur on veterinary indications. In the absence of data on pregnancy, breastfeeding or serious systemic diseases, a risk-benefit assessment is necessary. Avoid concomitant use with other systemic pesticides without medical consultation. If adverse reactions appear (vomiting, diarrhea, lethargy), discontinue treatment and contact your veterinarian.
Safety of the drug for the species
The formulation favors ingredients with a high safety profile for the canine species. Since effectiveness requires contact of the parasite with the host, it is not possible to completely exclude the transmission of pathogens before eliminating the pest. Any side effects are generally transient (mild gastrointestinal disturbances). Pay attention to possible interactions with drugs acting on the central nervous system. Keep out of reach of children and animals.
Precautions
A clinical visit is recommended before starting treatment. For home administration, extract only one tablet at a time and place the blister in a safe place. Wash hands after use and avoid contact in case of personal hypersensitivity to the components. For sporting animals, check compatibility with anti-doping regulations. In case of adverse reactions in cohabiting animals, consult your veterinarian.
Method of administration
The tablets can be offered directly into the mouth or mixed with food. For selective subjects, it is possible to divide them into snacks or wet food, ensuring that the entire dose is taken. The dosage is calibrated for dogs weighing 2 kg; for different weights consult your veterinarian. If you forget, administer the dose as soon as possible without doubling the next one. If immediate vomiting occurs, evaluate with the professional the need for a new administration.
Treatment program
The treatment plan varies based on environmental risk and clinical status. For parasite control, periodic cycles linked to seasonality are recommended. For digestive well-being, continuous use can promote intestinal balance. In case of dermatitis or recurrent infestations, the product must be included in a multimodal strategy (environmental control, topical therapies). The veterinarian will define the ideal duration and frequency of treatment.
Target species
Small dogs, specifically subjects around 2 kg of body weight. Use in other non-compliant species or categories must be managed exclusively by the veterinary surgeon.